Articles tagged with Vaccine Research
Researchers found that Covid vaccines effectively protect HIV-positive individuals, particularly after a third booster shot. The study also revealed a surprisingly strong cellular immune response in HIV-positive people, similar to those in healthy individuals.
Researchers found that lncRNA MVIH is overexpressed in cervical cancer tumors and associated with younger age, lymph node metastasis, tumor invasion depth, and squamous cell type. This suggests its potential as a diagnostic biomarker for cervical cancer.
Researchers from Tokyo Medical and Dental University discovered three novel STAT1 variants that cause Mendelian susceptibility to mycobacterial disease (MSMD) in response to the BCG vaccine. The variants result in loss of function of the STAT1 protein, preventing an appropriate immune response.
A global study published in Nature finds that the unvaccinated face significant prejudice in most countries, with many vaccinated people harboring discriminatory attitudes towards them. The study suggests that this prejudice could lead to severe consequences for society, including hindered vaccination uptake and increased mistrust.
A large study from Argentina found that COVID-19 vaccines remain effective in preventing death in children and adolescents, regardless of the predominant circulating variant. The study's results show that vaccinated children had a 67% reduced risk of death related to COVID-19 infection during the omicron period.
A new tablet-based vaccine has shown long-lasting protection against bacteria that cause urinary tract infections (UTIs) in mice. The vaccine was found to be comparable to antibiotics in efficacy, with durable antibody responses lasting for the lifetime of a mouse.
Parental COVID-19 vaccination was associated with lower risk of hospitalization in children under 5, supporting widespread vaccination recommendations for young children. The study's results reinforce the importance of parental immunization during high-risk periods.
Studies found that sotrovimab reduced the risk of severe covid-19 outcomes by 46% compared to molnupiravir. However, no benefit was found for common heart drugs like ARBs in a randomised controlled trial.
A team of scientists at Boston Children's Hospital created a new tool to analyze vaccine responses, enabling better understanding of immune system reactions. The Immune Signatures Data Resource contains data from 53 studies covering 24 different vaccines.
A study by Children's Hospital of Philadelphia researchers found that COVID-19 vaccination results in higher antibody concentrations compared to natural infection, providing robust protection for mothers during pregnancy. The study also suggests optimal vaccine timing can maximize the transfer of antibodies to babies.
A study found that males younger than 40 years old who received the Moderna COVID-19 vaccine had the highest rates of myocarditis, but overall cases are rare. The study suggests that choosing specific vaccines for certain populations may maximize benefits and minimize adverse events.
Researchers at the University of Calgary found that vaccination against influenza significantly lowers the risk of stroke among adults. The study analyzed health records of over four million Albertans and showed that the risk of stroke was reduced in all age groups, not just those at high risk.
Researchers from McGill University found that pneumococcal vaccination uptake is low among adults at high risk in Canada. Despite the importance of pneumococcal vaccination to prevent pneumonia and other forms of pneumococcal disease, many people missed opportunities for vaccination.
A UK study found substantial monkeypox transmission before symptoms appear, with 53% of cases occurring pre-symptomatically. The study's findings have important implications for infection control globally and may affect isolation and contact tracing policies.
A research group at Osaka Metropolitan University developed a nanovaccine that delivers cancer antigens to dendritic cells, inducing strong cellular immunity. The new system, using positively charged cationic lipids, increases cytokine production by approximately 100 times compared to previous designs.
A monoclonal antibody was found to be up to 88.2% effective at preventing malaria infection in healthy, non-pregnant adults during a six-month malaria season in Mali, Africa. The study suggests that this antibody could complement other measures to protect vulnerable groups from seasonal malaria.
A UCLA study found that Black Americans' mistrust of medical professionals and lower vaccination rates are linked to poor healthcare experiences, not past injustices. Researchers call for changes within the medical community to build better trust with Black patients.
A Yale-designed 'Prime and Spike' nasal vaccine approach can help combat COVID-19 by bolstering immune responses in the respiratory system. The strategy, which involves a combination of a prime vaccination and a spike protein booster administered directly into the nostril, has been shown to reduce viral shedding and transmission.
A recent study by West Virginia University sociologists found that individuals with paranormal beliefs are more likely to be hesitant about vaccination. These beliefs, which include astrology and spirits, lead to a lack of confidence in science and vaccines, including the COVID-19 shot.
A review of COVID-19 and other adult vaccination efforts found that cash transfers and lottery programs had limited outcomes in increasing vaccination rates, with some studies showing a slight over 2% increase in coverage. Non-cash incentives also showed no significant impact on vaccination uptake.
A recent study published in JAMA Network Open found that human papillomavirus (HPV) vaccination effectiveness differs significantly depending on the age at which it is administered. The researchers analyzed self-reported data from female participants and discovered that HPV vaccination is most effective when administered earlier in life.
The COVID-19 pandemic led to a marked decrease in routine childhood immunization rates in India, with significant implications for the country's immunization program and COVID-19 recovery policies. The study highlights the urgent need for catch-up vaccination campaigns and investments in health systems.
A survey of six European countries found strong public support for transferring COVID-19 vaccines to poorer nations and prioritizing those with the greatest need. Europeans consistently prioritized individuals most vulnerable, employed individuals, or those who lost income during the pandemic over unemployed individuals.
Researchers found that reduced NA activity enables HA mutations to become more neutral, and that this process is crucial for predicting future flu strains. The study aims to improve flu vaccine accuracy by understanding the interactions between HA and NA genes.
Researchers have reverse-engineered a virus linked to chronic kidney disease in cats and described its mechanism of infection. The feline morbillivirus, or FeMV, can spread from host to host through urine, similar to the zoonotic Nipah virus.
A new Danish-led study has demonstrated a way to strengthen the body's own ability to fight HIV, even when standard treatment is paused. The study found that monoclonal antibodies and Romidepsin can help the immune system recognize and kill infected cells.
Researchers analyzed 408 patients receiving immune checkpoint inhibitor therapy and found no increased risk of side effects from receiving both immunotherapy and the vaccine. The study supports NCCN's recommendations for COVID-19 vaccination in people with cancer, citing strong protection against severe COVID-19 for all variants.
Researchers created theoretical models to explain geographical clustering of vaccine hesitancy, attributing it to both social selection and social influence. The models found that these two processes independently generate clusters of high hesitancy, with social selection playing a key role when societies trust propaganda.
The Independent Task Force Report emphasizes the need for a One Health approach to prevent or respond adequately to the next pandemic. Key findings highlight the importance of 'Smart Surveillance' to identify high-threat pathogens and invest in R&D for innovative diagnostics, antiviral strategies, and therapeutic research.
New research highlights the need for comprehensive approaches to address COVID-19 vaccine hesitancy in UK South Asian communities, citing factors such as trust in authorities and media. The study's findings emphasize the complexity of the issue, beyond simplistic 'pro' or 'anti' Vaccine views.
A Johns Hopkins Medicine study found that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly among older adults. The results support the CDC vaccination guidelines recommending COVID-19 boosters and highlight the importance of continued research on factors affecting immunity.
Researchers developed a highly effective and safe Zika vaccine technology that prevents systemic infection in pregnant mice and stimulates an immunogenic reaction. The vaccine was tested in various mouse models, proving safe and protective against the virus.
A recent study finds that exposure to proteins in common foods, vaccines, bacteria, and viruses can prime the immune system to attack SARS-CoV-2, potentially providing protection against COVID-19. The study's findings suggest that individuals with a history of exposure to these agents may be less susceptible to severe illness.
Researchers inculcated an avirulent Fusarium strain into Cavendish bananas, enhancing their resistance to Panama disease. This innovative approach may provide a sustainable solution for combating the devastating impact of Tropical Race 4 on global banana crops.
Researchers found that HPV vaccination rates rose significantly during the pandemic, particularly among younger children and adolescents. The study suggests that the increased vaccination rates may be attributed to changes in healthcare access and scheduling.
A recent study found that COVID-19 vaccination rates in NYC schools differed significantly by race and ethnicity, with majority Asian students having the highest rate at 66.2%. Vaccination rates also varied by borough, with Manhattan having the highest rate and Staten Island the lowest. The study suggests that understanding these diffe...
A recent study analyzing COVID-19 vaccination rates in New York City schools reveals significant disparities based on race and ethnicity. The research also highlights geographical variations in vaccination rates across the city.
Researchers at La Jolla Institute for Immunology discovered how Zika virus forces dendritic cells to churn out lipid molecules, allowing the virus to build copies of itself. This study provides a major step forward in developing antiviral therapies against multiple flavivirus infections.
A new study has suggested that recommended VACV-based vaccines will mount a robust immune response against the 2022 monkeypox virus. The research found that the genetic mutations observed in MPXV-2022 may not significantly affect vaccine-induced immunity.
A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine has begun enrolling adult volunteers. The trial aims to expand the vaccine supply and provide important information on immunogenicity, safety, and tolerability of alternative dosing approaches.
Researchers found that RK-33 inhibits the ability of SARS-CoV-2 to replicate in host cells, making it a potential broad-spectrum antiviral agent. The study showed that RK-33's antiviral capability remains consistent across four SARS-CoV-2 variants.
Researchers have identified two effective antibodies that neutralize all known strains of COVID-19, including Delta and Omicron variants. These breakthrough antibodies could eliminate the need for repeated booster vaccinations and strengthen immune systems, especially in at-risk populations.
A third vaccine dose offers better protection against Omicron infection and hospitalization compared to two doses. The study found that a third dose maintained longer protection against infection for a longer time.
The study found that a booster shot's effectiveness is the primary factor influencing people's willingness to receive it. Those who believe in vaccine efficacy are more likely to accept the booster shot, especially if it is made by Moderna or Pfizer. A partisan divide persists, with Democrats more willing and Republicans less willing.
A population-based retrospective cohort study found that COVID-19 vaccination during pregnancy is not associated with an increased risk of preterm birth, small for gestational age at birth, or stillbirth. The study concluded that COVID-19 vaccination during pregnancy can inform evidence-based decision-making about its safety.
A PSU study reveals that Republican voters and Black people are among the most hesitant to get vaccinated against COVID-19. The research suggests a regional approach may be more effective than a universal one in boosting vaccination rates.
Research reveals that smaller artificial cells lead to greater separation of molecules, allowing for a new approach to manipulate material properties. This discovery has potential applications in pharmaceuticals and cosmetics industries.
Researchers found no excess mortality in Massachusetts from February to June 2022, despite rising COVID-19 cases and hospitalizations. This suggests high levels of immunity benefiting those at highest risk from SARS-CoV-2 infection.
Researchers compared HPV prevalence among women born in the 1980s, 1990s, and before/after vaccination periods. The study found significant differences in HPV prevalence between these groups.
Advanced cervical cancer rates have been rising in the US, with a significant increase among White women and higher prevalence among Black women, particularly those in their mid-to-late 50s. The study found that obesity and older age at first birth may contribute to the rise in this type of cervical cancer.
Researchers estimated long-term effectiveness of Pfizer-BioNTech COVID-19 vaccine against SARS-CoV-2 infection and critical infections among 3.2 million South Korean adolescents. The study found high vaccine effectiveness in preventing severe illnesses.
A large Canadian study found no association between Covid-19 vaccination during pregnancy and increased risks of preterm birth or stillbirth. The study analyzed data from over 85,000 births and concluded that vaccination is effective against Covid-19 in pregnant individuals and their newborns.
Researchers discovered that presenting COVID-19 vaccine side effects in the context of other risks, such as motor vehicle death rates, increases people's intention to take the vaccine. Adding a simple qualitative risk level, like 'very low risk', also boosts intentions.
A new MIT model simulates vaccine allocation strategies to predict the effect on cumulative deaths and infections in the US. The research finds that allocating more than 50% of available doses to non-vaccinated individuals can significantly increase lives saved and reduce infections.
A double-blind study found that 12.5% of placebo-treated individuals and 1% of BCG-treated individuals met criteria for confirmed COVID-19, indicating a 92% vaccine effectiveness. The BCG-vaccinated group also displayed protective effects against other infectious diseases, including fewer symptoms and reduced disease events.
Researchers found that two new techniques can help reduce needle fear in primary-aged children, including a distraction game and positive memory reframing. The study involved 41 children and showed promising results for broad vaccination programs.
Researchers assessed the effectiveness of adding a Pfizer-BioNTech booster to two doses of CoronaVac, finding reduced risk of symptomatic SARS-CoV-2 infection. The study used national data from nearly 14 million vaccinated individuals in Malaysia.
A recent study suggests that the BCG vaccine is effective in preventing tuberculosis (TB) in children under 5 years old. However, adolescents and adults may require additional protection to maintain immunity beyond childhood. The researchers emphasize the need for booster vaccinations and new TB vaccines to supplement the BCG vaccine.
A research team at the University of Oklahoma has developed a new approach to triggering an adaptive immune response. The study presents a method to create molecules that can integrate into cells, cause stress on their membrane, and release signals that recruit immune cells to their location.
The new tuberculosis vaccine candidate VPM1002 shows its safety and efficacy in a study of HIV-exposed and non-HIV-exposed newborns. The vaccine has fewer side effects compared to the existing BCG vaccine, and elicits a similar immune response.